Prevalence of the factor V(Leide) mutation among autopsy patients with pulmonary thromboembolic disease using an improved method for factor V(Leiden) detection

American Journal of Clinical Pathology

Volumn 111, Issue 3, 1999, Pages 413-417

  Gorman, Timothy E ^a   Arcot, Anuradha N ^a   Baker, Peter ^a   Prior, Thomas W ^a   Brandt, John T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Activated protein C resistance; Autopsy; Factor V(Leiden) mutation; Pulmonary embolism; Thromboembolism; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5; DNA; PRIMER DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; CHILD; DNA DETERMINATION; FEMALE; GENE MUTATION; GENETIC LINKAGE; HUMAN; INFANT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOEMBOLISM; CAUCASIAN; CHEMISTRY; GENETICS; HETEROZYGOTE; HISPANIC; MIDDLE AGED; NEGRO; NEWBORN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; UNITED STATES; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; AUTOPSY; CHILD; CHILD, PRESCHOOL; DNA; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR V; FEMALE; HETEROZYGOTE; HISPANIC AMERICANS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OHIO; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PULMONARY EMBOLISM; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0032587981     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/111.3.413     Document Type: Article

References (14)

1. Leiden mutation in non-European populations. Thromb Haemost. 1997;77:329-331.
2. Dahlback B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood. 1995;85:607-614.
3. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
4. Kalafatis M, Bertina RM, Rand MD, et al. Characterization of the molecular defect in factor VR506Q. J Biol Chem. 1995;270:4053-4057.
5. Leiden (activated protein C resistance). Blood. 1995;85:1504-1508.
6. Leiden. Lancet. 1995;346:1133-1134.
7. Forsthoefel KF, Papp AC, Snyder PJ, et al. Optimization of DNA extraction from formalin-fixed tissue and its clinical application in Duchenne muscular dystrophy. Am J Clin Pathol. 1992;98:98-104.
8. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1982.
9. Gandrille M, Alhenc-Gelas M, Aiach M. A rapid screening method for the factor V Avg506Gln mutation. Blood Coagul Fibrinolysis. 1995;6:245-248.
10. Chamberlain JS, Gibbs RA, Ranier JE, et al. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988;16:11141-11156.
11. Leiden mutation. Thromb Haemost. 1996;76:510-513.
12. Morgenthaler TI, Ryu JH. Clinical characteristics of fatal pulmonary embolism in a referral hospital. Mayo Clinic Proc. 1995;70:417-424.
13. Ridker PM, Hennekens CH, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912-917.
14. Salzman EW, Hirsh J. The epidemiology, pathogenesis, and natural history of venous thrombosis. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and Thrombosis: Basic Principles and Practice. 3rd ed. Philadelphia, Pa: Lippincott; 1994:1275-1296.